Bath & Body Works, Inc. $BBWI Stake Boosted by Allianz Asset Management GmbH

Allianz Asset Management GmbH boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 58.8% in the third quarter, HoldingsChannel.com reports. The firm owned 263,628 shares of the company’s stock after acquiring an additional 97,640 shares during the period. Allianz Asset Management GmbH’s holdings in Bath & Body Works were worth $6,791,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Parkside Financial Bank & Trust boosted its holdings in shares of Bath & Body Works by 24.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after buying an additional 364 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its position in Bath & Body Works by 3.7% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock valued at $430,000 after purchasing an additional 600 shares during the last quarter. State of Wyoming increased its stake in shares of Bath & Body Works by 6.2% in the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock valued at $338,000 after purchasing an additional 661 shares during the period. Vident Advisory LLC raised its holdings in shares of Bath & Body Works by 2.8% during the second quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock valued at $756,000 after buying an additional 692 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its holdings in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Stock Up 0.3%

Shares of NYSE:BBWI opened at $23.12 on Tuesday. The firm has a fifty day moving average of $21.02 and a two-hundred day moving average of $24.27. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $41.87. The firm has a market capitalization of $4.73 billion, a P/E ratio of 7.11, a price-to-earnings-growth ratio of 1.02 and a beta of 1.54.

Bath & Body Works (NYSE:BBWIGet Free Report) last posted its quarterly earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). The firm had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The firm’s revenue for the quarter was down 1.0% on a year-over-year basis. During the same period last year, the business earned $0.49 earnings per share. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. Equities research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 6th. Stockholders of record on Friday, February 20th will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date is Friday, February 20th. Bath & Body Works’s payout ratio is presently 24.62%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Bank of America reduced their price target on Bath & Body Works from $40.00 to $32.00 and set a “buy” rating for the company in a research report on Thursday, November 20th. New Street Research set a $26.00 target price on Bath & Body Works in a research report on Monday, November 24th. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, November 12th. Citigroup dropped their price target on shares of Bath & Body Works from $35.00 to $21.00 and set a “buy” rating on the stock in a research report on Friday, November 21st. Finally, Robert W. Baird set a $20.00 price objective on Bath & Body Works in a research report on Wednesday, December 17th. Five analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $23.53.

View Our Latest Stock Report on BBWI

Insider Activity

In other Bath & Body Works news, Director Francis Hondal bought 3,343 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average price of $14.99 per share, for a total transaction of $50,111.57. Following the purchase, the director directly owned 21,554 shares in the company, valued at $323,094.46. This trade represents a 18.36% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Steven E. Voskuil acquired 20,000 shares of the stock in a transaction dated Friday, November 21st. The stock was bought at an average price of $15.04 per share, for a total transaction of $300,800.00. Following the purchase, the director owned 33,925 shares of the company’s stock, valued at $510,232. The trade was a 143.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 33,513 shares of company stock valued at $500,442 in the last quarter. 0.27% of the stock is currently owned by corporate insiders.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Recommended Stories

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.